ORIC Pharmaceuticals Grants 14,800 Stock Options, 2,400 Restricted Stock Units to New Employee

• ORIC Pharmaceuticals granted 14,800 non-qualified stock options and 2,400 restricted stock units to one new non-executive employee on Nov. 2, 2026.
• The employee joined in October 2026; the awards fall under the 2022 Inducement Equity Incentive Plan.
• Options vest 25% on the grant date’s first anniversary, with 1/36 of the remaining shares vesting monthly thereafter.
• Restricted stock units vest in equal thirds on the grant date’s first three anniversaries.
• Vesting requires continued employment or service through each applicable vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061630PRIMZONEFULLFEED9868845) on November 06, 2026, and is solely responsible for the information contained therein.